Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

The effect of glycoprotein (GP) IIb/IIIa receptor inhibitor, Tirofiban, on the microcirculation in patients undergoing high risk coronary stenting

The effect of glycoprotein (GP) IIb/IIIa receptor inhibitor, Tirofiban, on the microcirculation in patients undergoing high risk coronary stenting. J Am Coll Cardiol. 2001; 37:31.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.